Nov. 12, 2018:
In this month’s Across the Consortium, we focus on strategies Big Ten cancer centers are using to assist those who have difficulty finding resources for their cancer treatment or prevention. We also highlight some recent discoveries in several cancer types.
Nov. 1, 2018: The Robert H. Lurie Comprehensive Cancer Center of Northwestern University (cancer.northwestern.edu), one of only 49 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers in the nation, is dedicated to scientific discovery, advancing medical knowledge, providing compassionate, state-of-the-art cancer care, and training the next generation of clinicians and scientists. Outstanding basic, translational, and clinical research complements a full range of prevention, early detection, treatment, rehabilitation, and palliative care programs for all types of cancer. Read More
Oct. 23, 2018: In this month's Across the Consortium, we highlight the innovative work of our member cancer centers across a wide spectrum of cancer care: from prevention to new approaches to treatment, from bench science to survivorship. Catch the latest from each member cancer center in this month's edition. Read More
Oct. 23, 2018: Big Ten investigators presented Phase Ib results of the BTCRC-LUN15-017 study during a poster session at the International Association for the Study of Lung Cancer's World Conference on Lung Cancer, Sept. 23-26 in Toronto. Read More
Oct. 22, 2018: Applications are now open for a nationwide integrative oncology training program. The Integrative Oncology (IO) Scholars program brings together oncology professionals in a free year-long course. Designed for the full spectrum of oncology care professionals, the program equips oncologists, nurses, physicians assistants, physical and occupational therapists, social workers, and psychologists with the knowledge and skills necessary to provide safe and evidence-based integration of complementary therapies in conventional oncology care. The course is funded by the National Cancer Institute and developed by researchers and clinicians at the University of Michigan (U-M) Medical School.
Oct. 1, 2018: Investigator Spotlight Borys Hrinczenko, MD, PhD, Breslin Cancer Center at Michigan State University Educational background MD: SUNY Downstate College of Medicine, Brooklyn, NY PhD: University of Kansas, Lawrence, KS Internship and Residency: Mayo Clinic, Rochester, MN Fellowship: National Institutes of Health, Bethesda, MD Research interests My main interest is in new therapies for lung cancer, including the use of immune checkpoint inhibitors, the same treatments for which James P. Allison and Tasuku Honjo were awarded the 2018 Nobel Prize in Medicine. At the Breslin Cancer Center, we have Phase I clinical trials using...
Sept. 29, 2018: The Big Ten Cancer Research Consortium (Big Ten CRC) has appointed internationally recognized breast cancer physician and researcher Ruth O’Regan, MD, as its chief scientific officer (CSO). Dr. O’Regan is the division head of hematology, medical oncology, and palliative care in the Department of Medicine at the University of Wisconsin School of Medicine and Public Health; and associate director for clinical research at the UW Carbone Cancer Center. Read More
Sept. 17, 2018: Big Ten cancer centers are enriched by dedicated researchers who are meeting cancer head-on with not only their intellect, but also their heart. In this edition of Across the Consortium, we applaud those who are making a difference in the clinic, in the lab, and in the community. Read More
Sept. 10, 2018: History has its transformative moments – instances that radically shape the future. Looking back, we see their significance, but in the moment their impact is still unseen. As the Big Ten Cancer Research Consortium (Big Ten CRC) celebrates its fifth year in 2018, we pause to reflect on milestones past and those on the horizon, through the words of some of our founding visionaries. Read More
Sept. 1, 2018: University of Michigan Rogel Cancer Center investigators Ryan Wilcox, MD, and Sumana Devata, MD, discuss their current research in these videos. Dr. Wilcox and Dr. Devata are members of the Big Ten CRC's Lymphoid Malignancies Clinical Trial Working Group. The University of Michigan is the Big Ten CRC's featured member for September. Learn more about the Rogel Cancer Center. Read More
University of Illinois
Indiana University
University of Iowa
University of Maryland
University of Michigan
Michigan State
University of Minnesota
University of Nebraska
Northwestern University
Penn State University
Purdue University
Rutgers State University
University of Wisconsin
University of Illinois at Chicago
© 2024 All rights reserved.
Big Ten Cancer Research Consortium
7676 Interactive Way, Suite 120, Indianapolis, IN 46278
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube